Jazz Pharmaceuticals (JAZZ) Change in Inventory (2010 - 2026)

Jazz Pharmaceuticals' Change in Inventory history runs 17 years deep, the most recent figure standing at $77.8 million for Q1 2026.

• In Q1 2026, Change in Inventory rose 118.54% year-over-year to $77.8 million; the TTM figure through Mar 2026 stood at $128.2 million (up 87.77% YoY), while the FY2025 annual figure was $86.0 million, up 88.93% from the prior year.
• Change in Inventory was $77.8 million for Q1 2026 at Jazz Pharmaceuticals, up from -$7.7 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $77.8 million in Q1 2026 to a low of -$7.7 million in Q4 2025.
• Historically, Change in Inventory has averaged $16.0 million across 5 years, with a median of $9.3 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Change in Inventory soared 1229.42% in 2024, then plunged 141.36% in 2025.
• A 5-year view of Change in Inventory shows it stood at -$816000.0 in 2022, then soared by 272.06% to $1.4 million in 2023, then jumped by 1229.42% to $18.7 million in 2024, then tumbled by 141.36% to -$7.7 million in 2025, then jumped by 1107.77% to $77.8 million in 2026.
• The last three Change in Inventory figures came in at $77.8 million (Q1 2026), -$7.7 million (Q4 2025), and $31.9 million (Q3 2025), per Business Quant data.